T-Cell Immunotherapy against Mutant KRAS for Pancreatic Cancer

N Engl J Med. 2022 Jun 2;386(22):2143-2144. doi: 10.1056/NEJMe2204283.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Humans
  • Immunotherapy* / methods
  • Pancreatic Neoplasms* / genetics
  • Pancreatic Neoplasms* / immunology
  • Pancreatic Neoplasms* / therapy
  • Proto-Oncogene Proteins p21(ras)* / antagonists & inhibitors
  • Proto-Oncogene Proteins p21(ras)* / genetics
  • T-Lymphocytes

Substances

  • KRAS protein, human
  • Proto-Oncogene Proteins p21(ras)